Should You Keep Chemed (CHE) Stock in Your Portfolio Now?

Chemed Corporation (CHE) is primed to grow in the upcoming quarters, backed by the promising prospects of the VITAS business. The company is set to capitalize on the positive trends of the global Hospice industry. Moreover, sound financial stability appears encouraging. However, the uncertainty of the macroeconomic challenges and competitive pressure remain our concerns for Chemed's operations. Upsides Favorable Hospice Industry Trends: Within the Hospice segment, we believe that Chemed is well-poised to re ...